Small and micro-cap roundup: final osteosarcoma survival data, Timmins gold step-outs, graphene battery cycling and a non-binding data center LOI.
Read more: aktiego.com/weekly-marke...
Full Disclaimer: aktiego.com/disclaimer/
@aktiego.bsky.social
@aktiego.bsky.socialSmall and micro-cap roundup: final osteosarcoma survival data, Timmins gold step-outs, graphene battery cycling and a non-binding data center LOI.
Read more: aktiego.com/weekly-marke...
Full Disclaimer: aktiego.com/disclaimer/
@aktiego.bsky.socialHemostemix now has full Bahamian approval for its VesCell Phase 1 study, which was described as enrolling back in August while approvals were pending. Breakdown on aktiego.com.
Read more: aktiego.com/sectors/biot...
#TSXV #Biotech #CellTherapy #ClinicalTrials #BiotechNews #RegenerativeMedicine
@chemcenterbio.bsky.socialThe Biggest Peptide Lie In Medical History Is Finally Exposed?
Laboratory data behind the peptide Dihexa was officially retracted following scientific investigations on animals only.
#dihexa #peptideresearch #biotechnews #neuroscience #clinicaltrials